-+ 0.00%
-+ 0.00%
-+ 0.00%
Tianjin Pharmaceutical (600488.SH): Dexamethasone API marketing application approved
Share
Listen to the news

Zhitong Finance App News, Tianjin Pharmaceutical (600488.SH) issued an announcement. Recently, the company received the “Notice of Approval of the Application for the Marketing of Chemical Ingredients” for dexamethasone approved and issued by the State Drug Administration. This drug is mainly used for allergic and autoimmune inflammatory diseases. This approval can further meet the diverse needs of downstream formulation customers, further enrich the company's product structure, give full play to the integrated advantages of API formulations, and help expand the company's business field.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending